Open Access Repository (ePrints)
Items where Author is "Admassie, E"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 5.
Admassie, E, Chalmers, L and Bereznicki, LR 
ORCID: 0000-0003-3974-3437 2017
, 'Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study'
, European Journal of Clinical Pharmacology, vol. 73, no. 12
, 1681–1689
, doi: https://doi.org/10.1007/s00228-017-2337-9.
ORCID: 0000-0003-3974-3437 2017
, 'Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study'
, European Journal of Clinical Pharmacology, vol. 73, no. 12
, 1681–1689
, doi: https://doi.org/10.1007/s00228-017-2337-9.
Admassie, E, Chalmers, L and Bereznicki, LR ORCID: 0000-0003-3974-3437 2017
, 'Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation'
, The American Journal of Cardiology, vol. 120, no. 7
, pp. 1133-1138
, doi: https://doi.org/10.1016/j.amjcard.2017.06.055.
ORCID: 0000-0003-3974-3437 2017
, 'Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation'
, The American Journal of Cardiology, vol. 120, no. 7
, pp. 1133-1138
, doi: https://doi.org/10.1016/j.amjcard.2017.06.055.
Admassie, E, Chalmers, L and Bereznicki, LR ORCID: 0000-0003-3974-3437 2017
, 'The Tasmanian Atrial Fibrillation Study: Transition to Direct Oral Anticoagulants 2011-2015'
, Cardiovascular Therapeutics, vol. 35, no. 3
, pp. 1-8
, doi: https://doi.org/10.1111/1755-5922.12254.
ORCID: 0000-0003-3974-3437 2017
, 'The Tasmanian Atrial Fibrillation Study: Transition to Direct Oral Anticoagulants 2011-2015'
, Cardiovascular Therapeutics, vol. 35, no. 3
, pp. 1-8
, doi: https://doi.org/10.1111/1755-5922.12254.
Admassie, E, Chalmers, L and Bereznicki, LR ORCID: 0000-0003-3974-3437 2018
, 'Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study'
, Journal of cardiovascular pharmacology and therapeutics
, pp. 1-8
, doi: https://doi.org/10.1177/1074248418769638.
ORCID: 0000-0003-3974-3437 2018
, 'Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study'
, Journal of cardiovascular pharmacology and therapeutics
, pp. 1-8
, doi: https://doi.org/10.1177/1074248418769638.
Admassie, E, Chalmers, L and Bereznicki, LR ORCID: 0000-0003-3974-3437 2018
, 'Thromboembolism and mortality in the Tasmanian Atrial Fibrillation Study'
, Journal of cardiovascular pharmacology and therapeutics, vol. 23, no. 4
, pp. 329-336
, doi: https://doi.org/10.1177/1074248418769638.
ORCID: 0000-0003-3974-3437 2018
, 'Thromboembolism and mortality in the Tasmanian Atrial Fibrillation Study'
, Journal of cardiovascular pharmacology and therapeutics, vol. 23, no. 4
, pp. 329-336
, doi: https://doi.org/10.1177/1074248418769638.